Lankenau Medical Center
Wynnewood, Pennsylvania, United States
Hospital in Wynnewood, Pennsylvania
100 E Lancaster Ave, Wynnewood, PA 19096
370 Beds
About Lankenau Medical Center
Lankenau Medical Center, part of Main Line Health, is a 370-bed acute care, teaching hospital in Wynnewood, Lower Merion Township, Pennsylvania.
There are 370 beds in Lankenau Medical Center.
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
National Cancer Institute (NCI)
89
Radiation Therapy Oncology Group
39
Alliance for Clinical Trials in Oncology
20
SWOG Cancer Research Network
20
Eastern Cooperative Oncology Group
17
ECOG-ACRIN Cancer Research Group
16
NRG Oncology
12
Gynecologic Oncology Group
11
NSABP Foundation Inc
9
Edwards Lifesciences
8
Boston Scientific Corporation
7
Clinical Trials at Lankenau Medical Center
During the past decade, Lankenau Medical Center conducted 120 clinical trials. In the 10-year time frame, 120 clinical trials started and 127 clinical trials were completed, i.e. on
average, 105.8% percent of trials that started reached the finish line to date. In the past 5 years, 35 clinical trials started and 49 clinical trials were completed. i.e. 140%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Hodgkin's Lymphoma
1999-04-01
2016-05-01
Completed
854
Chemotherapy Plus Radiation Therapy in Treating Patients With Stage II or Stage III Anal Cancer
1998-10-01
2016-12-01
Completed
682
Lymph Node Removal in Treating Patients With Stage I or Stage II Non-small Cell Lung Cancer
1999-07-01
2011-01-01
Completed
1,023
Radiation Therapy With or Without Optional Tamoxifen in Treating Women With Ductal Carcinoma in Situ
1999-12-01
2022-05-20
Completed
636
Chemotherapy and Radiation Therapy in Treating Patients With Stomach Cancer
1999-11-01
Completed
Prognostic Study of Metastases in Patients With Stage I, Stage II, or Stage III Non-small Cell Lung Cancer That Can Be Removed by Surgery
1999-07-01
2011-10-01
Completed
1,310
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women
1999-05-01
2012-08-01
Completed
19,747
Carboplatin, Paclitaxel, and Radiation Therapy With or Without Thalidomide in Patients With Stage III Non-small Cell Lung Cancer
2000-01-01
2010-03-01
Terminated
589
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Lankenau Medical Center" #1 sponsor was "National Cancer Institute (NCI)" with 89 trials, followed by "Radiation Therapy Oncology Group" with 39 trials
sponsored, "Alliance for Clinical Trials in Oncology" with 20 trials sponsored, "SWOG Cancer Research Network" with 20 trials sponsored and "Eastern Cooperative Oncology Group"
with 20 trials sponsored. Other sponsors include 144 different institutions and
companies that sponsored additional 69 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Lankenau Medical Center"
#1 collaborator was "National Cancer Institute (NCI)" with 153 trials as a collaborator, "NRG Oncology" with 51 trials as a collaborator, "Cancer and Leukemia Group B" with 10 trials as a collaborator, "SWOG Cancer Research Network" with 10 trials as a collaborator and "NCIC Clinical Trials Group" with 9 trials as a collaborator. Other collaborators include 118 different institutions and companies that were
collaborators in the rest 92 trials.
Clinical Trials Conditions at Lankenau Medical Center
According to Clinical.Site data, the most researched conditions in "Lankenau Medical Center" are
"Breast Cancer" (23 trials), "Lung Cancer" (19 trials), "Colorectal Cancer" (11 trials), "Prostate Cancer" (11 trials) and "Coronary Artery Disease" (9 trials). Many other conditions were trialed in "Lankenau Medical Center" in a lesser frequency.
Clinical Trials Intervention Types at Lankenau Medical Center
Most popular intervention types in "Lankenau Medical Center" are "Drug" (217 trials), "Other" (127 trials), "Biological" (88 trials), "Radiation" (73 trials) and "Procedure" (65 trials). Other intervention types were less common.
The name of intervention was led by "Laboratory Biomarker Analysis" (59 trials), "Quality-of-Life Assessment" (45 trials), "Paclitaxel" (35 trials), "Questionnaire Administration" (29 trials) and "Carboplatin" (24 trials). Other intervention names were less common.
Clinical Trials Genders at Lankenau Medical Center
The vast majority of trials in "Lankenau Medical Center" are
251 trials for "All" genders, 69 trials for "Female" genders and 14 trials for "Male" genders.
Clinical Trials Status at Lankenau Medical Center
Currently, there are 145 active trials in "Lankenau Medical Center".
2 are not yet recruiting,
49 are recruiting,
93 are Active, not recruiting,
and 1 are Enrolling by invitation.
In total, there were 150 completed trials in Lankenau Medical Center,
4 suspended trials,
and 19 terminated clinical trials to date.
Out of the total trials that were conducted in Lankenau Medical Center, 8 "Phase 1"
clinical trials were conducted, 113 "Phase 2" clinical
trials and 145 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 8 trials, and there were
also 49 trials that are defined as “Not Applicable".